Biofrontera (BFRI) Common Equity (2020 - 2025)
Historic Common Equity for Biofrontera (BFRI) over the last 6 years, with Q3 2025 value amounting to -$2.6 million.
- Biofrontera's Common Equity fell 14667.27% to -$2.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$2.6 million, marking a year-over-year decrease of 14667.27%. This contributed to the annual value of $4.4 million for FY2024, which is 751.1% down from last year.
- As of Q3 2025, Biofrontera's Common Equity stood at -$2.6 million, which was down 14667.27% from -$4.7 million recorded in Q2 2025.
- Biofrontera's 5-year Common Equity high stood at $23.9 million for Q4 2022, and its period low was -$17.4 million during Q3 2021.
- In the last 5 years, Biofrontera's Common Equity had a median value of $5.2 million in 2023 and averaged $6.6 million.
- Per our database at Business Quant, Biofrontera's Common Equity soared by 43275.53% in 2024 and then crashed by 14667.27% in 2025.
- Biofrontera's Common Equity (Quarter) stood at $11.3 million in 2021, then soared by 110.6% to $23.9 million in 2022, then plummeted by 79.93% to $4.8 million in 2023, then decreased by 7.51% to $4.4 million in 2024, then crashed by 158.22% to -$2.6 million in 2025.
- Its last three reported values are -$2.6 million in Q3 2025, -$4.7 million for Q2 2025, and $500000.0 during Q1 2025.